In 2018 the United States invested $371 million in tuberculosis research and development (R&D). South Africa invested $4.5 million (R64,9 million) – a dramatic decrease on 2017, but still high when measured as a proportion of all R&D spending in the country.
Social justice organisations have released an open letter in which they question the Limpopo Health Department’s decision to release provincial bursary holders from their contractual obligations. RHAP has in its possession a letter circulated to health professionals inviting them to a meeting to discuss the decision which will affect approximately 540 health professionals who have received funding from the department.
Each of South Africa’s nine provinces is supposed to have an HIV and TB plan that guides provincial implementation of the National Strategic Plan. Here’s Spotlight’s analysis of KwaZulu-Natal’s plan.
South Africa has made great strides in scaling up HIV testing and increasing HIV suppression in patients receiving antiretroviral treatment (ART), but is still struggling to reach ART coverage targets and is falling short of HIV prevention goals.